Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 11 | 2025 | 169 | 6.340 |
Why?
|
| Anticoagulants | 5 | 2025 | 493 | 2.010 |
Why?
|
| Emergency Service, Hospital | 23 | 2024 | 1064 | 1.980 |
Why?
|
| Outpatients | 2 | 2023 | 141 | 1.410 |
Why?
|
| Noninvasive Ventilation | 2 | 2020 | 70 | 1.290 |
Why?
|
| Opioid-Related Disorders | 4 | 2024 | 490 | 1.180 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2025 | 25 | 1.130 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2024 | 67 | 1.030 |
Why?
|
| Physicians | 2 | 2022 | 464 | 1.000 |
Why?
|
| Qualitative Research | 4 | 2025 | 667 | 1.000 |
Why?
|
| Hospitalization | 4 | 2025 | 1338 | 0.910 |
Why?
|
| Emergency Medicine | 4 | 2024 | 188 | 0.880 |
Why?
|
| Cannula | 2 | 2020 | 26 | 0.870 |
Why?
|
| Harm Reduction | 1 | 2024 | 33 | 0.850 |
Why?
|
| Restraint, Physical | 1 | 2023 | 34 | 0.830 |
Why?
|
| Humans | 48 | 2025 | 62462 | 0.780 |
Why?
|
| Transsexualism | 1 | 2022 | 13 | 0.780 |
Why?
|
| Buprenorphine | 2 | 2022 | 190 | 0.740 |
Why?
|
| Transgender Persons | 1 | 2022 | 69 | 0.710 |
Why?
|
| Emergency Medical Services | 2 | 2023 | 260 | 0.690 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 76 | 0.690 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 147 | 0.680 |
Why?
|
| Electric Countershock | 2 | 2020 | 101 | 0.660 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 172 | 0.640 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2025 | 706 | 0.640 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 93 | 0.630 |
Why?
|
| Patient Discharge | 1 | 2023 | 505 | 0.630 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1537 | 0.630 |
Why?
|
| Occupational Diseases | 1 | 2020 | 268 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 177 | 0.580 |
Why?
|
| Coronavirus Infections | 2 | 2021 | 202 | 0.580 |
Why?
|
| Patient Safety | 1 | 2020 | 242 | 0.570 |
Why?
|
| Patient Care Team | 1 | 2020 | 335 | 0.550 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 295 | 0.550 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6486 | 0.540 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 216 | 0.540 |
Why?
|
| Health Personnel | 1 | 2020 | 361 | 0.530 |
Why?
|
| Spinal Puncture | 1 | 2016 | 15 | 0.520 |
Why?
|
| Headache | 1 | 2016 | 58 | 0.500 |
Why?
|
| Rivaroxaban | 1 | 2015 | 19 | 0.490 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 113 | 0.450 |
Why?
|
| Analgesics | 1 | 2015 | 102 | 0.450 |
Why?
|
| Pain Management | 2 | 2021 | 162 | 0.450 |
Why?
|
| Heparin | 2 | 2025 | 116 | 0.420 |
Why?
|
| Social Media | 3 | 2022 | 124 | 0.420 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 431 | 0.410 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2024 | 87 | 0.390 |
Why?
|
| Analgesia | 2 | 2022 | 31 | 0.370 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 831 | 0.370 |
Why?
|
| Acute Disease | 2 | 2024 | 670 | 0.350 |
Why?
|
| Female | 11 | 2025 | 32378 | 0.320 |
Why?
|
| Adult | 12 | 2025 | 16567 | 0.320 |
Why?
|
| United States | 8 | 2024 | 7696 | 0.320 |
Why?
|
| Male | 10 | 2025 | 29368 | 0.310 |
Why?
|
| Policy | 3 | 2024 | 52 | 0.310 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 202 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 1582 | 0.250 |
Why?
|
| Middle Aged | 6 | 2025 | 17294 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2024 | 107 | 0.210 |
Why?
|
| Naloxone | 1 | 2024 | 60 | 0.210 |
Why?
|
| Seizures | 1 | 2024 | 141 | 0.210 |
Why?
|
| Shoulder Dislocation | 1 | 2022 | 9 | 0.200 |
Why?
|
| Aged | 7 | 2024 | 14203 | 0.200 |
Why?
|
| Point-of-Care Testing | 1 | 2023 | 43 | 0.200 |
Why?
|
| Brain Concussion | 1 | 2023 | 35 | 0.200 |
Why?
|
| Fibrinolytic Agents | 1 | 2024 | 169 | 0.200 |
Why?
|
| Fear | 1 | 2023 | 68 | 0.200 |
Why?
|
| Appendicitis | 1 | 2023 | 78 | 0.200 |
Why?
|
| Anesthesia | 1 | 2022 | 50 | 0.200 |
Why?
|
| Guideline Adherence | 1 | 2025 | 306 | 0.200 |
Why?
|
| Blood Transfusion | 1 | 2023 | 157 | 0.190 |
Why?
|
| Nurses | 1 | 2023 | 104 | 0.190 |
Why?
|
| Gender Identity | 1 | 2022 | 67 | 0.190 |
Why?
|
| Methoxyflurane | 1 | 2021 | 1 | 0.180 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2021 | 9 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 532 | 0.180 |
Why?
|
| Brain Injuries | 1 | 2023 | 140 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 131 | 0.180 |
Why?
|
| Ureterolithiasis | 1 | 2021 | 13 | 0.180 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 45 | 0.180 |
Why?
|
| Accidental Falls | 1 | 2022 | 128 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2023 | 310 | 0.170 |
Why?
|
| Abscess | 1 | 2021 | 78 | 0.170 |
Why?
|
| Wounds and Injuries | 1 | 2023 | 237 | 0.170 |
Why?
|
| Recurrence | 1 | 2022 | 630 | 0.170 |
Why?
|
| Drainage | 1 | 2021 | 154 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 104 | 0.170 |
Why?
|
| Comorbidity | 1 | 2023 | 1117 | 0.160 |
Why?
|
| Accountable Care Organizations | 1 | 2020 | 67 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 194 | 0.150 |
Why?
|
| Drug Overdose | 1 | 2020 | 130 | 0.140 |
Why?
|
| Occupational Exposure | 1 | 2020 | 315 | 0.140 |
Why?
|
| Coma | 1 | 2017 | 13 | 0.140 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 40 | 0.140 |
Why?
|
| Cultural Diversity | 1 | 2017 | 53 | 0.130 |
Why?
|
| Resuscitation | 1 | 2017 | 66 | 0.130 |
Why?
|
| Medicare | 1 | 2020 | 614 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 5390 | 0.130 |
Why?
|
| Asthma | 1 | 2020 | 433 | 0.130 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 56 | 0.130 |
Why?
|
| Head | 1 | 2016 | 55 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2017 | 197 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 142 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 661 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2023 | 784 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 752 | 0.120 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 106 | 0.120 |
Why?
|
| Contrast Media | 1 | 2017 | 421 | 0.120 |
Why?
|
| Massachusetts | 1 | 2020 | 2061 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 783 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 384 | 0.110 |
Why?
|
| Child | 1 | 2023 | 4429 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 959 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2020 | 2033 | 0.100 |
Why?
|
| Internet | 1 | 2015 | 462 | 0.090 |
Why?
|
| Electrocardiography | 2 | 2024 | 548 | 0.090 |
Why?
|
| Communication | 2 | 2023 | 568 | 0.070 |
Why?
|
| Registries | 2 | 2021 | 869 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 768 | 0.060 |
Why?
|
| Computers | 1 | 2024 | 49 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2024 | 104 | 0.050 |
Why?
|
| Chest Pain | 1 | 2024 | 83 | 0.050 |
Why?
|
| Lidocaine | 1 | 2022 | 33 | 0.050 |
Why?
|
| Conscious Sedation | 1 | 2022 | 39 | 0.050 |
Why?
|
| Triage | 1 | 2024 | 115 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 190 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 68 | 0.050 |
Why?
|
| Research | 1 | 2024 | 192 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 71 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 118 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 127 | 0.050 |
Why?
|
| Heart Rate | 1 | 2023 | 319 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 15 | 0.040 |
Why?
|
| Methadone | 1 | 2022 | 134 | 0.040 |
Why?
|
| Decision Trees | 1 | 2021 | 51 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 163 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 66 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 34 | 0.040 |
Why?
|
| Hospitals | 1 | 2024 | 392 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2023 | 470 | 0.040 |
Why?
|
| Software | 1 | 2023 | 381 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 5554 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 338 | 0.040 |
Why?
|
| Opiate Substitution Treatment | 1 | 2022 | 204 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2023 | 355 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 299 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1636 | 0.040 |
Why?
|
| Cough | 1 | 2021 | 183 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 561 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 1003 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 405 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 851 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 37 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 20 | 0.030 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 24 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 59 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 52 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 66 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 727 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 252 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5288 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 414 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 3246 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1359 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 159 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 282 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 686 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 928 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 481 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1272 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 864 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4610 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2529 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6147 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3737 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2638 | 0.020 |
Why?
|